Epidemiology of Birth Defects Based on a Birth Defect Surveillance System from 2005 to 2014 in Hunan Province, China

Donghua Xie1,2, Tubao Yang1, Zhiyu Liu2

  • 1Department of Epidemiology and Health Statistic, School of Public Health, Central South University, 110 Xiangya Road, Changsha, Hunan, 410078, P.R of China.

Plos One
|January 27, 2016
PubMed

Insights

Birth defect (BD) prevalence in Hunan, China, increased from 2005-2014, with higher risks observed in urban areas, male infants, and mothers over 35. Targeted interventions are crucial for reducing BD rates.

Area of Science:

  • Epidemiology
  • Public Health
  • Perinatal Medicine

Background:

  • Birth defects (BDs) pose a significant global health challenge.
  • Understanding regional epidemiological trends is crucial for effective public health strategies.

Purpose of the Study:

  • To analyze the epidemiology of birth defects in perinatal infants in Hunan Province, China, from 2005 to 2014.
  • To identify trends and risk factors associated with BDs in this population.

Main Methods:

  • Utilized surveillance data from 52 registered hospitals in Hunan Province (2005-2014).
  • Included perinatal infants (28 weeks gestation to 7 days postnatal).
  • Calculated prevalence rates and odds ratios to assess associations with infant gender, maternal age, and urban/rural residence.

Main Results:

  • Observed an average BD prevalence of 191.84 per 10,000 perinatal infants, with a significant upward trend.
  • Higher BD risks were associated with urban areas (OR=1.20), male infants (OR=1.19), and mothers aged over 35 (OR=1.24).
  • Congenital heart defects (CHD) and congenital malformation of kidney (CMK) prevalence increased, while congenital hydrocephalus and neural tube defects (NTDs) decreased.

Conclusions:

  • Significant changes in specific BD prevalence rates were noted in Hunan's perinatal infants over a decade.
  • Urban residence, male gender, and advanced maternal age (≥35 years) are linked to different BD prevalence rates.
  • Implementing advanced diagnostic technologies, enhancing monitoring, and strengthening public education are vital for BD reduction.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...